We are live on
!
Find out more
Squarepoint Portfolio holdings
AUM
$85.1B
1-Year Est. Return
20.93%
This Fund
S&P 500
This Quarter
Est. Return
+7.16%
1 Year Est. Return
+20.93%
3 Year Est. Return
+51.38%
5 Year Est. Return
+34.63%
10 Year Est. Return
+146.23%
AUM
$7.42B
AUM Growth
+$1.24B
(+20%)
Cap. Flow
+$985M
Cap. Flow
% of AUM
13.27%
Top 10 Holdings %
Top 10 Hldgs %
10.68%
Holding
3,037
New
854
Increased
791
Reduced
777
Closed
600
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$49.3M |
| 2 |
Intuit
INTU
|
+$48.7M |
| 3 |
Costco
COST
|
+$47.9M |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$47.4M |
| 5 |
Vanguard Real Estate ETF
VNQ
|
+$45.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$41M |
| 2 |
Dollar General
DG
|
+$39M |
| 3 |
Biogen
BIIB
|
+$36.8M |
| 4 |
iShares US Real Estate ETF
IYR
|
+$29.8M |
| 5 |
Waste Management
WM
|
+$29.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.19% |
| 2 | Consumer Discretionary | 16.12% |
| 3 | Healthcare | 11.21% |
| 4 | Financials | 10.17% |
| 5 | Industrials | 9.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2251
Hackett Group
HCKT
$245M
| $117K | ﹤0.01% |
+10,460
| New | +$135K |
|
|
ORGS
2252
DELISTED
Orgenesis Inc. Common Stock
ORGS
| $117K | ﹤0.01% |
+2,318
| New | +$126K |
|
|
SPPI
2253
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
| $117K | ﹤0.01% |
28,694
-79,271
| -73% | -$301K |
|
|
ALR
2254
DELISTED
AlerisLife Inc
ALR
| $117K | ﹤0.01% |
+23,040
| New | +$110K |
|
2255
MediWound
MDWD
$183M
| $116K | ﹤0.01% |
+4,416
| New | +$113K |
|
|
SVC
2256
Service Properties Trust
SVC
$1.1B
| $116K | ﹤0.01% |
2,908
-23,770
| -89% | -$905K |
|
|
CNTG
2257
DELISTED
Centogene N.V. Common Shares
CNTG
| $115K | ﹤0.01% |
+12,145
| New | +$155K |
|
|
DZSI
2258
DELISTED
DZS Inc. Common Stock
DZSI
| $115K | ﹤0.01% |
12,320
-1,785
| -13% | -$17.9K |
|
2259
AstroNova
ALOT
$223M
| $114K | ﹤0.01% |
+14,245
| New | +$104K |
|
2260
Liberty Energy
LBRT
$2.83B
| $114K | ﹤0.01% |
14,302
-12,128
| -46% | -$84.4K |
|
|
LNAI
2261
Lunai Bioworks
LNAI
$10.6M
| $114K | ﹤0.01% |
+398
| New | +$125K |
|
|
SBT
2262
DELISTED
Sterling Bancorp, Inc. Common Stock
SBT
| $114K | ﹤0.01% |
37,979
+22,425
| +144% | +$71.6K |
|
|
SRT
2263
DELISTED
Startek Inc.
SRT
| $113K | ﹤0.01% |
+21,571
| New | +$111K |
|
2264
BayCom
BCML
$346M
| $112K | ﹤0.01% |
+10,898
| New | +$125K |
|
|
IVAC
2265
DELISTED
Intevac Inc
IVAC
| $112K | ﹤0.01% |
20,409
-7,464
| -27% | -$43.1K |
|
|
EIGR
2266
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
| $112K | ﹤0.01% |
+458
| New | +$142K |
|
|
EMKR
2267
DELISTED
Emcore Corp
EMKR
| $112K | ﹤0.01% |
3,458
+1,444
| +72% | +$47.7K |
|
2268
Twin Disc
TWIN
$335M
| $111K | ﹤0.01% |
+21,890
| New | +$131K |
|
|
ARA
2269
DELISTED
American Renal Associates Holdings, Inc
ARA
| $111K | ﹤0.01% |
16,040
-399
| -2% | -$2.62K |
|
|
TNAV
2270
DELISTED
Telenav Inc.
TNAV
| $110K | ﹤0.01% |
+30,549
| New | +$148K |
|
2271
Pure Cycle
PCYO
$257M
| $107K | ﹤0.01% |
11,925
-801
| -6% | -$7.54K |
|
2272
SiriusPoint
SPNT
$2.98B
| $107K | ﹤0.01% |
+15,432
| New | +$125K |
|
|
SYRS
2273
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
| $107K | ﹤0.01% |
+1,211
| New | +$138K |
|
|
YJ
2274
Yunji
YJ
$6.55M
| $106K | ﹤0.01% |
1,447
-373
| -20% | -$37.3K |
|
|
VGR
2275
DELISTED
Vector Group Ltd.
VGR
| $106K | ﹤0.01% |
15,377
-196,389
| -93% | -$1.34M |
|
Similar funds
Squarepoint's Q3 2020 Portfolio in Review
As of Q3 2020, Squarepoint held 3,037 positions worth $7.42B, up 20% from $6.18B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Squarepoint deployed $985M of net new capital in Q3 2020, opening 854 new positions and adding to 791 existing holdings. Its largest new stake was Salesforce: 186,017 shares worth $46.8M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was Pfizer, an estimated $41M trimmed.
- Squarepoint's largest Q3 2020 buy was Salesforce: 186,017 shares worth $46.8M.
- Squarepoint added most to Visa in Q3 2020, an estimated $49.3M increase.
- Squarepoint's biggest Q3 2020 reduction was Pfizer, cutting an estimated $41M.
- Squarepoint fully exited Biogen in Q3 2020, selling an estimated $36.8M.
- Squarepoint's ten largest holdings make up 11% of its $7.42B portfolio in Q3 2020.
- Squarepoint opened 854 new positions and closed 600 in Q3 2020.
- Squarepoint's portfolio value rose 20% quarter-over-quarter to $7.42B.
Based on Squarepoint's 13F filing for Q3 2020, filed 16 Nov 2020.